Pharmacogenomics and Ethnic Diversity: Optimizing Drug Response Across Populations
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 January 2026 | Viewed by 21
Special Issue Editors
Interests: pharmacogenomics; ancestry; ethnic groups
Special Issues, Collections and Topics in MDPI journals
2. Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-200, AM, Brazil
Interests: pharmacogenomics; infectious diseases; malaria
Special Issue Information
Dear Colleagues,
Variation in individuals’ response to drugs is a global issue that requires further research. Pharmacogenomics has already identified numerous genetic variants that enable us to preemptively determine the toxicity and therapeutic failure of drugs. However, some ethnic groups are underrepresented in pharmacogenomic studies, as most clinical evidence is published based on European populations. Recent studies suggest that other genetic variants outside the known panels may explain the variation in drug response in people with other ethnic backgrounds, such as Afro-Americans and Latin Americans. Therefore, we invite authors to submit pharmacogenomics studies that include underrepresented populations to enhance the robustness of evidence in these populations.
Dr. Fernanda Rodrigues-Soares
Prof. Dr. Gisely Cardoso De Melo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenomics
- pharmacogenetics
- ethnic groups
- population genetics
- ancestry
- drug response
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
